سعر كينسورام 0.5مجم 30 قرص 2024

Pramipexole 0.5 mg tablets, 30 per pack (3 strips) (Kinsoram, EGPI/Ramapharma, Egypt); non-ergot dopamine agonist for Parkinson's disease.

• Treatment of Parkinson's disease (US label).Population: AdultsDailyMed (U.S. National Library of Medicine)
• Treatment of moderate-to-severe primary restless legs syndrome (US label).Population: AdultsDailyMed (U.S. National Library of Medicine)

• None listed in the US label.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Falling asleep during activities of daily living (including driving), sometimes without warning, and somnolence; reassess and consider discontinuation if this occurs.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Other warnings in the US label include symptomatic orthostatic hypotension, impulse-control/compulsive behaviours, hallucinations and psychotic-like behaviour, dyskinesia and a withdrawal-emergent hyperpyrexia and confusion on rapid dose reduction.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• There are no adequate data on developmental risk in pregnant women; no adverse developmental effects in rabbits, but postnatal growth was inhibited in rats at clinically relevant exposures.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• No data on presence in human milk; inhibition of lactation is expected because pramipexole inhibits prolactin secretion.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Pramipexole: Non-ergot dopamine agonist that stimulates striatal dopamine receptors, with higher affinity for D3 than D2 or D4 receptor subtypes.